Results 1 to 10 of about 24,185 (223)

4-Aminopyridine treatment for nerve injury resulting from radical retro-pubic prostatectomy: a single-center double-blind, randomized, placebo-controlled study [PDF]

open access: goldTrials
Background Prostate cancer (PCa) is the most common non-cutaneous malignancy in men and leads to the second most common cause of cancer related mortality in men. Early detection of PCa allows for a potentially curative intervention.
Ahmed Ghazi   +4 more
doaj   +4 more sources

KCNA1 gain‐of‐function epileptic encephalopathy treated with 4‐aminopyridine [PDF]

open access: yesAnnals of Clinical and Translational Neurology, 2023
Precision medicine for Mendelian epilepsy is rapidly developing. We describe an early infant with severely pharmacoresistant multifocal epilepsy. Exome sequencing revealed the de novo variant p.(Leu296Phe) in the gene KCNA1, encoding the voltage‐gated K+
Peter Müller   +10 more
doaj   +2 more sources

4-aminopyridine – the new old drug for the treatment of neurodegenerative diseases [PDF]

open access: goldPharmacia, 2019
In this review are described the preclinical and clinical pharmacological data as well as new therapeutic indications for the use of 4-aminopyridine.
Ivanka Kostadinova, Nikolai Danchev
doaj   +4 more sources

Neuroprotective Properties of 4-Aminopyridine. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm, 2021
As an antagonist of voltage-gated potassium (Kv) channels, 4-aminopyridine (4-AP) is used as symptomatic therapy in several neurologic disorders. The improvement of visual function and motor skills and relieve of fatigue in patients with MS have been attributed to 4-AP.
Dietrich M, Hartung HP, Albrecht P.
europepmc   +4 more sources

Hydroxyapatite and Silicon-Modified Hydroxyapatite as Drug Carriers for 4-Aminopyridine [PDF]

open access: goldCrystals, 2021
Adsorption and desorption properties of nano-hydroxyapatite (HAP) and silicon-modified hydroxyapatite (Si–HAP) were investigated with 4-aminopyridine (fampridine-4AP). The novelty of this research is the investigation of the suitability of the previously
Laura Marincaș   +7 more
doaj   +2 more sources

Two new zinc(II) acetates with 3– and 4–aminopyridine: syntheses and structural properties [PDF]

open access: yesActa Chimica Slovenica, 2015
The synthesis and characterization of two new zinc(II) coordination compounds with 3– and 4–aminopyridine are reported. They were obtained after dissolving Zn(CH3COO)2·2H2O in different solutions of 3– and 4–aminopyridine. The products were characterized
Brina Dojer   +3 more
doaj   +2 more sources

Optical triggered seizures using a caged 4-Aminopyridine [PDF]

open access: yesFrontiers in Neuroscience, 2015
Animal models of epilepsy are critical not only for understanding the fundamental mechanism of epilepsy but also for testing the efficacy of new antiepileptic drugs and novel therapeutic interventions.
Mingrui eZhao   +7 more
doaj   +4 more sources

Responsiveness to progesterone and potassium channel blockers 4-aminopyridine, tetraethylammonium and free Ca(2+) contentration in spermatozoa of patients with oligozoospermia/leucocytospermia [PDF]

open access: diamondThe Ukrainian Biochemical Journal, 2018
The present study was undertaken to evaluate [Ca2+]i signals that occur in human sperm cells exposed in vitro to three diverse compounds; progesterone, 4-aminopyridine (a highly effective inducer of hyperactivation in human sperm) and tetraethylammonium.
R. V. Fafula   +4 more
doaj   +2 more sources

Functional improvement in individuals with chronic spinal cord injury treated with 4-aminopyridine: A systematic review [PDF]

open access: yesFrontiers in Neurology, 2022
Study designSystematic review.ObjectiveTo provide current evidence on the efficacy of 4-aminopyridine (4-AP) to bring about functional improvement in individuals with chronic traumatic spinal cord injury (SCI).MethodsThe Medline (PubMed), Web of Science ...
Martin Paredes-Cruz   +6 more
doaj   +2 more sources

Dynamic walking features and improved walking performance in multiple sclerosis patients treated with fampridine (4-aminopyridine) [PDF]

open access: gold, 2015
Background: Impaired walking capacity is a frequent confinement in Multiple Sclerosis (MS). Patients are affected by limitations in coordination, walking speed and the distance they may cover.
Philipp M. Keune   +7 more
openalex   +5 more sources

Home - About - Disclaimer - Privacy